Identification and purification of immunogenic proteins from nonliving promastigote polyvalent Leishmania vaccine (Leishvacin®)

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 2, 2003, Pages 193-199

  Cardoso, Sandra Regina Afonso ^a   Da Silva, João Carlos França ^a   Da Costa, Roberto Teodoro ^a   Mayrink, Wilson ^a   Melo, Maria Norma ^a   Marques Michalick, Marilene Suzan ^a   Willi Liu, Ibrahim Afrânio ^a   Fujiwara, Ricardo Toshio ^a   Nascimento, Evaldo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Immunogenic proteins; Leishvacin ; Tegumentary leishmaniasis

Indexed keywords

GAMMA INTERFERON; LEISHMANIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELUTION; FEMALE; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROPIONIBACTERIUM ACNES; PROTEIN ANALYSIS; PROTEIN PURIFICATION; STATISTICAL ANALYSIS; VACCINATION;

ANIMALIA; CORYNEBACTERIUM; CORYNEBACTERIUM PARVUM; LEISHMANIA AMAZONENSIS;

EID: 0037523561     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822003000200001     Document Type: Article

References (34)

1. Afonso LCC, Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infection and Immunity 61: 2952-2959, 1993.
2. Antunes CF, Mayrink W, Magalhaes PA, Costa CA, Melo MN, Michalick MM, Williams P, Oliveira Lima A, Vieira JF, Schettini AM. Controlled field trials of a vaccine against New World Cutaneous Leishmaniasis. International Journal of Epidemiology 15: 572-580, 1986.
3. Ashford RW, Desjeux P, Raadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitology Today 8: 104-105, 1992.
4. Bretscher PA, Wei G, Menon JN, Bielefeldt H. Establishment of stable, cell mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257: 539-542, 1992.
5. Cáceres-Dittmar G, Tapia FJ, Sanches MA, Yamamura M, Uyemura K, Modlin RL, Bloom BR, Convit J. Determination of the cytokine profile in American Cutaneous Leishmaniasis using the polymerase chain reaction. Journal of Clinical Investigation 91: 500-505, 1993.
6. Chatelain R, Varkila K, Coffman R L. IL-4 induces a Th2 response in Leishmania major infected mice. Journal of Immunology 148:1182-1187, 1992.
7. Convit J, Ulrich M, Fernández CT. The clinical and immunological spectrum of American cutaneous leishmaniasis. Transaction of the Royal. Society of Tropical Medicine and Hygiene 87: 444-448, 1993.
8. De Luca PM, Mayrink W, Alves CA, Coutinho SG, Oliveira MP, Bertho AL, Toledo VPCP, Costa CA, Genaro O, Mendonça SCF. Evaluation of the stability and immunogenicity of autoclaved and non-autoclaved preparations of the vaccine against tegumentary leishmaniasis. Vaccine 17: 1179-1185, 1999.
9. Desjeux P. Aspects de Saluté publique et lutte. In: Dedet, JP (ed) Les Leishmanioses. Paris AUPELF-EREFF P, 219-238, 1999.
10. Dixon W, Massey JFJR. Introductin to Estatistical Analysis. Tokio: McGraw-Hill Booh, The normal distribution. Cap. 5. p.56, 1969.
11. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Journal of Immunology 146: 286-291, 1991.
12. Heinzel FP, Sadick MD, Mutha SS, Holaday BJ, Coffman RL, Locksley, RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Journal of Experimental Medicine 169: 3149-3155, 1989.
13. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
14. Liew FY. Cell-mediated immunity in experimental cutaneous leishmaniasis. Parasitology Today 2:264-270, 1986.
15. Locksley RM, Louis JA. Immunology of leishmaniasis. Current Opinion in Immunology 4: 413-218, 1992.
16. Lowry OH, Rosembrough NJ, Randall RJ. Protein measurement with folin reagent. Journal of Biological Chemistry 193: 265-275, 1951.
17. Marzochi KB, Marzochi MA, Silva AF, Grativol N, Duarte R, Confort EM, Moddaber F. Phase I study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil. Memórias do Instituto Oswaldo Cruz 93: 205-212, 1998.
18. Mayrink W. Tratamento da Leishmaniose Tegumentar Americana utilizando vacina. Anais Brasileiro de Dermatologia 66: 55-58, 1992.
19. Mayrink W, Da Costa CA, Magalhães PA, Melo MN, Dias M, Oliveira Lima A, Michalick MM, Williams P. A field trial of a vaccine against American dermal leishmaniasis. Transaction of the Royal Society of Tropical Medicine and Hygiene 73: 385, 1979.
20. Mayrink W, Magalhaes PA, Michalik MSM, Da Costa CA, Oliveira Lima A, Melo MN, Toledo VPCP, Nascimento E, Dias M, Genaro O, Hermeto MV, Williams. Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil. Parasitologia 34: 159-165, 1992.
21. Mayrink W, Williams P, Da Costa CA, Magalhães PA, Melo MN, Dias M, Oliveira Lima A, Michalik MM, Carvalho EF, Barros GC, Sessa PA, Alencar JA An experimental vaccine against American dermal leishmaniasis: experience in the Espirito Santo, Brazil. Annals of Tropical Medical and Parasitology 79: 259-269, 1985.
22. Mendonça SE, De Luca PM, Mayrink W, Restom TG, Conceição-Silva F, Da Cruz AM, Bertho AL, Da Costa CA, Genaro O, Toledo VP, Coutinho SG. Characterization of human T lymphocytemediated immune response induced by vaccine against American tegumentary leishmaniasis. American Journal of Tropical Medicine and Hygiene 55: 195-201, 1995.
23. Mora AM, Mayrink W, Da Costa RT, Da Costa CA, Genaro O, Nascimento, E. Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (L.) amazonensis. Revista do Instituto de Medicina Tropical de São Paulo 41: 243-248, 1999.
24. Nascimento E, Mayrink W, Da Costa CA, Michalick MM, Melo MN, Barros GC, Dias M, Antunes CMF, Lima MS, Toboada DC, Liu TY. Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses. Infection and Immunity 58: 2198-2203, 1990.
25. Pessoa SB. Segunda nota sobre a vacinação preventiva na leishmaniose tegumentar americana com leptomonas mortas. Revista Paulista de Medicina 19: 1-9, 1941.
26. Pessoa SB, Pestana BR. Ensaio sobre a vacinação preventiva na leishmaniose tegumentar amaricana. Revista de Biologia e Higiene 10: 157-161, 1940.
27. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. Journal of Clinical Investigation 91: 1390-1395, 1993.
28. Russell D, Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. Journal of Immunology 140: 1272-1279, 1988.
29. Sadick MD, Heinzel BJ, Holaday BJ, Pu RT, Dawkins, RS, Locksley, RM. Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T-cell dependent, interferon mechanism. Journal of Experimental Medicine 171:151-127, 1990.
30. Scott P. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Experimental Parasitology 68: 369-372, 1989.
31. Scott P. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology 147: 3149-3155. 1991.
32. Scott P, Notovitz P, Coffman RI, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. Journal of Experimental Medicine 168: 1675-1684, 1988.
33. Sypek JP, Chung CL, Mayor SH, Subramanyan JM, Goldman SI, Sceburth DS, Wolf SF, Schaub RG. Resolution of cutaneous leishmaniasis: interleukin 12 initiated protective T helper type 1 immune response. Journal of Experimental Medicine 177: 1797-1802, 1993.
34. Tafuri WL, Barbosa AA, Genaro O, França Silva JC, Michalick MM, Mayrink W, Nascimento E. Histopathology and immunochemical studies of type 3 and type 4 complement receptor in the liver or spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Revista do Instituto de Medicina Tropical de São Paulo 38: 81-89, 1996.